Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Merck & Co. Inc. | 32 | 1 | 4 | 0 | €124.00 | €125.34 | 1.079% |
| Neurocrine Bioscience | 33 | 0 | 4 | 0 | €124.15 | €140.87 | 13.465% |
| AbbVie Inc. | 30 | 0 | 9 | 0 | €161.64 | €175.39 | 8.509% |
| Krystal Biotech | 18 | 0 | 1 | 0 | €165.40 | €180.00 | 8.827% |
| Johnson & Johnson | 38 | 1 | 6 | 0 | €139.10 | €187.15 | 34.546% |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | €160.54 | €200.06 | 24.615% |
| Alnylam Pharmace. | 39 | 1 | 3 | 1 | €207.20 | €244.57 | 18.034% |
| Sarepta Therapeutics | 3 | 0 | 2 | 0 | €151.50 | €247.50 | 63.366% |
| United Therapeutics | 22 | 0 | 3 | 0 | €296.60 | €289.92 | -2.252% |
| Biogen Inc. | 50 | 1 | 2 | 0 | €212.00 | €293.22 | 38.313% |
| Amgen Inc. | 26 | 0 | 1 | 0 | €296.05 | €300.48 | 1.496% |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | €262.50 | €315.00 | 20.000% |
| Medpace Holdings Inc | 11 | 0 | 2 | 0 | €380.00 | €419.64 | 10.431% |
| Vertex Pharmaceuticals Inc. | 50 | 2 | 5 | 0 | €443.05 | €429.29 | -3.106% |
| Eli Lilly Corp. | 59 | 0 | 12 | 0 | €833.60 | €824.11 | -1.138% |
| Regeneron Pharmaceuticals Inc. | 41 | 1 | 5 | 0 | €991.80 | €1,025.4 | 3.383% |